ProCE Banner Activity

Strategies to Mitigate Adverse Events with Asparaginase Treatment in Patients With ALL

Slideset Download
Download this slideset from a live CCO symposium for an expert overview on identifying and managing adverse events associated with asparaginase-based therapy in patients with ALL, including discussion of hepatotoxicity, thrombosis, pancreatitis, hypertriglyceridemia, and factors contributing to their development.

Released: December 15, 2021

Expiration: December 14, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Jazz Pharmaceuticals

Servier Oncology Global Medical and Patient Affairs

Servier Pharmaceuticals